Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

We recently compiled a list of the Louis Navellier’s Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other stocks. Louis ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

Amgen subsidiary deCODE Genetics is building ... "With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI ...

The Commission advises the use of BMI solely as a marker to screen for potential obesity ... Eli Lilly, and Amgen. Rubino has served (unpaid) as a member of the scientific advisory board for ...

Investors with a lot of money to spend have taken a bearish stance on Amgen AMGN. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

The latest trading session saw Amgen (AMGN) ending at $267.10, denoting a -1.14% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.12% for the ...

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Amgen's market standing. Stay informed and make well-considered decisions with our ...

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation ...

An official ribbon-cutting ceremony took place Friday for Amgen's new manufacturing plant in Holly Springs. It's at the CaMP Helix Innovation Park. The celebration also included a ground-breaking ...